Kevin Dagbay

Company: Keros Therapeutics

Job title: Principal Scientist

Seminars:

Exploring Fc-Fusion Design, Characterization & AI Integration for Improving Drug Discovery 9:30 am

Harnessing the extracellular domain, explore Keros Therapeutics’ focus on molecular engineering Delve into design and characterization of Fc-fusion molecules Utilizing data insights to form strategic development for AI integration in drug discoveryRead more

day: Day Two